CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 11.25
+0.42 (3.73%)
Jul 9, 2025, 4:35 PM GMT+1
CRISM Therapeutics Revenue
In the year 2024, CRISM Therapeutics had annual revenue of 25.00K GBP, down -44.44%.
Revenue
25.00K
Revenue Growth
-44.44%
P/S Ratio
179.83
Revenue / Employee
6.25K
Employees
4
Market Cap
4.50M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
CRISM Therapeutics News
- 9 days ago - AIM Market Roundup: Mobile Tornado, Mediazest, Pri0r1ty Intelligence - The Armchair Trader
- 2 months ago - AIM Market Roundup: Surface Transforms, AFC Energy, Empyrean Energy - The Armchair Trader